Biocon Biologics
Rhonda Duffy has a wealth of experience in the pharmaceutical industry, currently serving as the Executive Vice President & Chief Operations Officer at Biocon Biologics. Prior to this role, Rhonda held various executive positions at LEO Pharma and LEO Pharma A/S, focusing on global product supply and value stream management. With a Ph.D in Natural Products Chemistry and Pharmacognosy from Trinity College Dublin, Rhonda's expertise in quality assurance, validation, and site management has been instrumental in the success of the companies Rhonda has worked for.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics